Skin manifestations of COVID-19 in children: Part 1.


Journal

Clinical and experimental dermatology
ISSN: 1365-2230
Titre abrégé: Clin Exp Dermatol
Pays: England
ID NLM: 7606847

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 12 08 2020
accepted: 13 08 2020
pubmed: 13 11 2020
medline: 7 4 2021
entrez: 12 11 2020
Statut: ppublish

Résumé

The current COVID-19 pandemic is caused by the SARS-CoV-2 coronavirus. The initial recognized symptoms were respiratory, sometimes culminating in severe respiratory distress requiring ventilation, and causing death in a percentage of those infected. As time has passed, other symptoms have been recognized. The initial reports of cutaneous manifestations were from Italian dermatologists, probably because Italy was the first European country to be heavily affected by the pandemic. The overall clinical presentation, course and outcome of SARS-CoV-2 infection in children differ from those in adults as do the cutaneous manifestations of childhood. In this review, we summarize the current knowledge on the cutaneous manifestations of COVID-19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe. In Part 1, we discuss one of the first and most widespread cutaneous manifestation of COVID-19, chilblain-like lesions. In Part 2, we review other manifestations, including erythema multiforme, urticaria and Kawasaki disease-like inflammatory multisystemic syndrome, while in Part 3, we discuss the histological findings of COVID-19 manifestations, and the testing and management of infected children, for both COVID-19 and any other pre-existing conditions.

Identifiants

pubmed: 33180982
doi: 10.1111/ced.14481
pmc: PMC9275402
doi:

Substances chimiques

Interferon Type I 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

444-450

Informations de copyright

© 2020 British Association of Dermatologists.

Références

Pediatr Dermatol. 2020 May;37(3):437-440
pubmed: 32374033
JAMA Pediatr. 2020 Apr 8;:
pubmed: 32267485
JAAD Case Rep. 2020 Apr 18;6(6):489-492
pubmed: 32363225
Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 28;41(0):E006
pubmed: 32220276
Respir Med. 2020 Jul;168:105996
pubmed: 32364961
Br J Dermatol. 2021 Jan;184(1):141-150
pubmed: 32779733
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Br J Dermatol. 2020 Oct;183(4):729-737
pubmed: 32562567
Blood. 2020 Jul 23;136(4):489-500
pubmed: 32492712
J Clin Invest. 2019 Jul 29;129(9):3625-3639
pubmed: 31355779
Br J Dermatol. 2020 Jul;183(1):71-77
pubmed: 32348545
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):e762-e764
pubmed: 32618033
Br J Dermatol. 2020 Sep;183(3):596-598
pubmed: 32460349
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213
pubmed: 32215952
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e291-e293
pubmed: 32330334
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Dermatol Ther. 2020 Sep;33(5):e13516
pubmed: 32378284
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e451-e452
pubmed: 32339344
JAMA Dermatol. 2020 Sep 1;156(9):998-1003
pubmed: 32584377
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Clin Exp Dermatol. 2020 Aug;45(6):746-748
pubmed: 32302422
Pediatr Dermatol. 2020 May;37(3):442-446
pubmed: 32445583
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
J Am Acad Dermatol. 2020 Aug;83(2):667-670
pubmed: 32380219
Mod Rheumatol. 2013 Sep;23(5):897-903
pubmed: 23001749
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e455-e457
pubmed: 32378743
JAMA Dermatol. 2020 Sep 1;156(9):992-997
pubmed: 32584397
Emerg Microbes Infect. 2020 Dec;9(1):687-690
pubmed: 32208840
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Lancet Respir Med. 2020 Jul;8(7):681-686
pubmed: 32473124
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e358-e360
pubmed: 32358813
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2620-2629
pubmed: 32474947
Lancet Infect Dis. 2020 Dec;20(12):1365-1366
pubmed: 32359410
J Clin Virol. 2020 Jun;127:104362
pubmed: 32305883
J Immunol. 2015 Aug 1;195(3):865-74
pubmed: 26091718
Intensive Care Med. 2020 Sep;46(9):1777-1778
pubmed: 32533198
J Am Acad Dermatol. 2020 Aug;83(2):486-492
pubmed: 32479979
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
Pediatr Dermatol. 2020 May;37(3):406-411
pubmed: 32386460
Mayo Clin Proc. 2014 Feb;89(2):207-15
pubmed: 24485134
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
Actas Dermosifiliogr (Engl Ed). 2020 Jun;111(5):426-429
pubmed: 32402369
Chin Med J (Engl). 2020 May 5;133(9):1039-1043
pubmed: 32118639
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e346-e347
pubmed: 32330324

Auteurs

D Andina (D)

Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

A Belloni-Fortina (A)

Pediatric Dermatology Unit, Department of Medicine DIMED, University of Padua, Padua, Italy.

C Bodemer (C)

Department of Dermatology, Hospital Necker Enfants Malades, Paris Centre University, Paris, France.

E Bonifazi (E)

Dermatologia Pediatrica Association, Bari, Italy.

A Chiriac (A)

Nicolina Medical Center, Iasi, Romania.

I Colmenero (I)

Department of Pathology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

A Diociaiuti (A)

Dermatology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

M El-Hachem (M)

Dermatology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

L Fertitta (L)

St Parascheva Infectious Diseases Hospital, Iasi, Romania.

D van Gysel (D)

Department of Pediatrics, O. L. Vrouw Hospital, Aalst, Belgium.

A Hernández-Martín (A)

Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

T Hubiche (T)

Department of Dermatology, Université Côte d'Azur, Nice, France.

C Luca (C)

Nicolina Medical Center, Iasi, Romania.

L Martos-Cabrera (L)

Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

A Maruani (A)

Department of Dermatology, Unit of Pediatric Dermatology, University of Tours, SPHERE-INSERM1246, CHRU Tours, Tours, France.

F Mazzotta (F)

Dermatologia Pediatrica Association, Bari, Italy.

A D Akkaya (AD)

Department of Dermatology, Ulus Liv Hospital, Istanbul, Turkey.

M Casals (M)

Department of Dermatology, Hospital Universitari de Sabadell, Barcelona, Spain.

J Ferrando (J)

Department of Dermatology, Hospital Clìnic, Barcelona, Spain.

R Grimalt (R)

Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.

I Grozdev (I)

Department of Dermatology, Children's University Hospital Queen Fabiola, Brussels, Belgium.

V Kinsler (V)

Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK.

M A Morren (MA)

Pediatric Dermatology Unit, Department of Pediatrics and Dermato-Venereology, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland.

M Munisami (M)

Department of Dermatology and Sexually Transmitted Diseases, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.

A Nanda (A)

As'ad Al-Hamad Dermatology Center, Kuwait City, Kuwait.

M P Novoa (MP)

Department of Dermatology, Hospital San Jose, Bogota, Colombia.

H Ott (H)

Division of Pediatric Dermatology, Children's Hospital Auf der Bult, Hannover, Germany.

S Pasmans (S)

Erasmus MC University Medical Center Rotterdam, Sophia Children's Hospital, Rotterdam, The Netherlands.

C Salavastru (C)

Department of Paediatric Dermatology, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

V Zawar (V)

Department of Dermatology, Dr Vasantrao Pawar Medical College, Nashik, India.

A Torrelo (A)

Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH